Cargando…
Changes in aldehyde dehydrogenase-1 expression during neoadjuvant chemotherapy predict outcome in locally advanced breast cancer
INTRODUCTION: Although neoadjuvant chemotherapy (NAC) for locally advanced breast cancer can improve operability and local disease control, there is a lack of reliable biomarkers that predict response to chemotherapy or long-term survival. Since expression of aldehyde dehydrogenase-1 (ALDH1) is asso...
Autores principales: | Alamgeer, Muhammad, Ganju, Vinod, Kumar, Beena, Fox, Jane, Hart, Stewart, White, Michelle, Harris, Marion, Stuckey, John, Prodanovic, Zdenka, Schneider-Kolsky, Michal Elisabeth, Watkins, D Neil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053180/ https://www.ncbi.nlm.nih.gov/pubmed/24762066 http://dx.doi.org/10.1186/bcr3648 |
Ejemplares similares
-
The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer
por: Alamgeer, Muhammad, et al.
Publicado: (2013) -
The role of chemotherapeutic drugs in the evaluation of breast tumour response to chemotherapy using serial FDG-PET
por: Schneider-Kolsky, Michal E, et al.
Publicado: (2010) -
Aldehyde dehydrogenase 1 as a predictor of the neoadjuvant chemotherapy response in breast cancer: A meta-analysis
por: Li, Jie, et al.
Publicado: (2018) -
The Evolution of Therapies in Non-Small Cell Lung Cancer
por: Boolell, Vishal, et al.
Publicado: (2015) -
Genomic Characterisation of Small Cell Lung Cancer Patient-Derived Xenografts Generated from Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Specimens
por: Leong, Tracy L., et al.
Publicado: (2014)